Crispr Therapeutics shares owned by Farallon Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Farallon Capital Management
from 13F filings
Historical chart of Farallon Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Farallon Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $29M | 530k | 54.01 |
| 2020-06-30 | $11M | 150k | 73.49 |
| 2020-03-31 | $15M | 350k | 42.41 |
| 2019-12-31 | $21M | 350k | 60.91 |
| 2019-09-30 | $23M | 560k | 40.99 |
| 2019-06-30 | $24M | 500k | 47.10 |
| 2019-03-31 | $26M | 725k | 35.72 |
| 2018-12-31 | $36M | 1.3M | 28.57 |
| 2018-09-30 | $45M | 1.0M | 44.35 |
| 2018-06-30 | $51M | 861k | 58.76 |
| 2018-03-31 | $30M | 645k | 45.71 |
| 2017-12-31 | $20M | 859k | 23.48 |
More positions owned by Farallon Capital Management
View all positions for Farallon Capital Management